JNK inhibitors with chemotherapeutic agents in a combination therapy for treating or preventing cancer and other proliferative disorders in refractory patients in particular

摘要

The use of a Jun N-terminal kinase inhibitor (JNK inhibitor) and a chemotherapeutic agent for the manufacture of a medicament for preventing, treating or managing cancer in a patient. Also disclosed is the use of one or more JNK inhibitors for the manufacture of a medicament for increasing the efficacy of cancer chemotherapeutic agents in a patient.